The Gulf Committee for Pharmaceutical Pricing held its fifty-eighth meeting in the Sultanate of Oman – Muscat at the Grand Millennium Hotel during the period (February 14-15, 2024) as part of the committees derived from the Health Council for the Gulf Cooperation Council (GCC) states, in accordance with the scheduled timings for the technical committees’ meetings, attended by representatives from the member states and participating entities.
The meeting’s agenda included several topics, such as: harmonizing the prices of a group of modern innovative drugs presented by the council states, discussing the unification of prices for modern innovative drugs, and studying the re-harmonization of drug prices in the council states. Additionally, the meeting discussed the circulars issued by the states regarding directing companies when objecting or reconsidering for the Health Council and studied the objection requests submitted by the companies and what has been done regarding the pricing of the related pharmaceutical preparations.
It’s worth noting that the Health Council aims to unify the efforts of the GCC states to develop health services and provide the highest level of health for the citizens of the council states. It fosters cooperation and coordination among the member states in health, preventive, therapeutic, and rehabilitative areas, spreads health awareness among the council’s citizens, defines the concepts of various health and scientific issues, works on harmonizing and prioritizing them, in addition to adopting the implementation of joint programs in the council states.
The council also focuses on establishing channels of interaction with global experiences and coordinating and enhancing cooperation in the health field, obtaining safe and effective medication of high quality and at reasonable prices through the unified drug purchasing program and the medical equipment, and the Gulf central pharmaceutical registration program for pharmaceutical companies and their products.
